Mirion Technologies Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Tom Logan

İcra Kurulu Başkanı

US$4.9m

Toplam tazminat

CEO maaş yüzdesi	15.1%
CEO görev süresi	19.8yrs
CEO sahipliği	0.8%
Yönetim ortalama görev süresi	2.6yrs
Yönetim Kurulu ortalama görev süresi	3.1yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Tom Logan'un ücretlendirmesi Mirion Technologies'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	-US$66m
Jun 30 2024	n/a	n/a	-US$65m
Mar 31 2024	n/a	n/a	-US$81m
Dec 31 2023	US$5m	US$738k	-US$97m
Sep 30 2023	n/a	n/a	-US$235m
Jun 30 2023	n/a	n/a	-US$270m
Mar 31 2023	n/a	n/a	-US$301m
Dec 31 2022	US$4m	US$700k	-US$277m
Sep 30 2022	n/a	n/a	-US$205m
Jun 30 2022	n/a	n/a	-US$204m
Mar 31 2022	n/a	n/a	-US$199m
Dec 31 2021	US$7m	US$326k	-US$222m

Tazminat ve Piyasa: Tom 'nin toplam tazminatı ($USD 4.88M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 1.92M ).

Tazminat ve Kazançlar: Tom şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.

CEO

Tom Logan (63 yo)

19.8yrs

Görev süresi

US$4,883,922

Tazminat

Mr. Thomas D. Logan, also known as Tom, serves Chief Executive Officer and Director of Mirion Technologies Inc. since 2005 and served as its Chairman and serves as Medical Group President since November 1,...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Thomas Logan	Founder	no data	US$4.88m	0.75% € 24.2m
Brian Schopfer	Chief Financial Officer	4.5yrs	US$1.88m	0.10% € 3.3m
Loic Eloy	Group President of Technologies	2.8yrs	US$842.32k	0.063% € 2.0m
Christopher Moore	Chief Accounting Officer & Principal Accounting Officer	2.7yrs	Veri yok	0.014% € 438.1k
James Cocks	Chief Technology Officer	1.1yrs	Veri yok	Veri yok
Emmanuelle Lee	Chief Legal Officer	6.8yrs	Veri yok	0.049% € 1.6m
Erin Schesny	Chief Marketing Officer	1.1yrs	Veri yok	Veri yok
Alison Ulrich	Chief Human Resources Officer	2.6yrs	Veri yok	0.015% € 496.0k
Shelia Webb	Chief Digital Officer	1.8yrs	Veri yok	Veri yok
Mark Siviter	Chief Revenue Officer	less than a year	Veri yok	Veri yok

2.6yrs

Ortalama Görev Süresi

49.5yo

Ortalama Yaş

Deneyimli Yönetim: 55I0 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.6 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Thomas Logan	Founder	19.8yrs	US$4.88m	0.75% € 24.2m
Robert Cascella	Independent Director	3.1yrs	US$180.00k	0.014% € 451.6k
John Kuo	Independent Director	3.1yrs	US$180.00k	0.028% € 912.8k
Lawrence Kingsley	Chairman of the Board	3.1yrs	US$170.00k	2.29% € 73.9m
Steven Etzel	Independent Director	no data	US$180.00k	0.028% € 912.8k
Jody Markopoulos	Independent Director	3.1yrs	US$170.00k	0.022% € 696.1k
Sheila Rege	Independent Director	2.2yrs	US$170.00k	0.0087% € 281.2k
Kenneth Bockhorst	Lead Independent Director	3.1yrs	US$182.50k	0.028% € 904.8k

3.1yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 55I0 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.1 yıldır).

Mirion Technologies Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

High number of new directors

Mirion Technologies, Inc., Annual General Meeting, Jun 04, 2024

Mirion Announces Resignation of Michael Rossi as Medical Group President, Effective November 1, 2023

Insufficient new directors

Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

Mirion Technologies, Inc. Announces Board Changes

Recent updates

Third quarter 2024 earnings released: US$0.066 loss per share (vs US$0.061 loss in 3Q 2023)

Mirion Technologies, Inc. Revises Financial Guidance for the Fiscal Year Ending December 31, 2024

New minor risk - Shareholder dilution

Mirion Technologies, Inc. to Report Q3, 2024 Results on Oct 29, 2024

New minor risk - Insider selling

Mirion Technologies, Inc. Reiterates Revenue Guidance for the Full Year Period Ending December 31, 2024

Second quarter 2024 earnings released: US$0.058 loss per share (vs US$0.14 loss in 2Q 2023)

New minor risk - Share price stability

Mirion Technologies, Inc. to Report Q2, 2024 Results on Aug 01, 2024

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

New minor risk - Shareholder dilution

No longer forecast to breakeven

First quarter 2024 earnings released: US$0.13 loss per share (vs US$0.22 loss in 1Q 2023)

Mirion Technologies, Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2024

High number of new directors

Mirion Technologies, Inc., Annual General Meeting, Jun 04, 2024

New minor risk - Shareholder dilution

Mirion Technologies, Inc. to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings released: US$0.49 loss per share (vs US$1.53 loss in FY 2022)

No longer forecast to breakeven

Full year 2023 earnings released: US$0.49 loss per share (vs US$1.53 loss in FY 2022)

Mirion Technologies, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024

Mirion Technologies, Inc. to Report Q4, 2023 Results on Feb 13, 2024

Mirion Technologies, Inc. (NYSE:MIR) acquired Nuclear Medicine Information Systems, LLC for $33 million.

Third quarter 2023 earnings released: US$0.061 loss per share (vs US$0.26 loss in 3Q 2022)

Mirion Technologies, Inc. Reiterates Revenue Guidance for the Twelve Month Period Ending December 31, 2023

Mirion Announces Resignation of Michael Rossi as Medical Group President, Effective November 1, 2023

Mirion Technologies, Inc. to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Profitability

No longer forecast to breakeven

Mirion Technologies, Inc. Updates Its Revenue Guidance for the Fiscal Year Ending December 31, 2023

New minor risk - Shareholder dilution

Mirion Technologies, Inc. to Report Q2, 2023 Results on Aug 02, 2023

Mirion Technologies Introduces Genie™? 4.0 Spectroscopy Software, Now with Flexible Licensing Options

Mirion Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $53.55 million.

Mirion Technologies, Inc. Reaffirms Revenue Guidance for the Fiscal Year Ending December 31, 2023

First quarter 2023 earnings released: US$0.22 loss per share (vs US$0.098 loss in 1Q 2022)

Mirion Technologies, Inc. Provides Revenue Guidance for the Fiscal Year Ending December 31, 2023

Full year 2022 earnings released

Mirion Technologies, Inc. to Report Q4, 2022 Results on Feb 14, 2023

No longer forecast to breakeven

Third quarter 2022 earnings released: US$0.26 loss per share (vs US$7.01 loss in 3Q 2021)

Mirion Technologies, Inc. Reaffirms Revenue Guidance for the Year 2022

Insufficient new directors

Mirion Technologies, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

Now 20% undervalued

Mirion Technologies, Inc. Announces Board Changes

Now 23% undervalued after recent price drop

Forecast breakeven date pushed back to 2023

Mirion Technologies, Inc. (NYSE:MIR) acquired ARINC Incorporated from Collins Aerospace.

Second quarter 2022 earnings released: US$0.32 loss per share (vs US$8.14 loss in 2Q 2021)

Mirion Technologies, Inc. to Report Q2, 2022 Results on Jul 29, 2022

Mirion Technologies, Inc. Appoints Christopher Moore as Principal Accounting Officer

First quarter 2022 earnings released: US$0.098 loss per share (vs US$6.18 loss in 1Q 2021)

Insufficient new directors

Mirion Technologies, Inc., Annual General Meeting, Jun 15, 2022

Mirion Technologies, Inc. Introduces New SaaS Option for its SunCHECK™ Quality Management Platform

Mirion Technologies, Inc. (NYSE:MIR) acquired Safeline Monitors Systems LLC for $1.5 million.

Full year 2021 earnings: Revenues in line with analyst expectations

Mirion Technologies, Inc. Announces Executive Changes

Mirion Technologies, Inc. Announces Executive Changes

Mirion Technologies, Inc. to Report Q4, 2021 Results on Feb 23, 2022

Mirion Technologies, Inc. Launches the Hyperion™ Compact Digital Radiation Tolerant Camera

First quarter 2022 earnings released: US$7.01 loss per share (vs US$3.58 loss in 1Q 2021)

Insufficient new directors

CEO Tazminat Analizi

CEO